00074-1055
Telisotuzumab Vedotin
Telisotuzumab Vedotin
INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION
Intravenous
TELISOTUZUMAB VEDOTIN
100.0
mg/mL
00074-1055-01
1 VIAL, SINGLE-DOSE in 1 CARTON (0074-1055-01) / 1 mL in 1 VIAL, SINGLE-DOSE
May 14, 2025
Immunotherapy
Drug Antibody Conjugate
c-MET
 
In Use